Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
New England Journal of Medicine, 09/25/09
Olanow CW et al. – Early treatment with rasagiline at a dose of 1 mg per day provided benefits that were consistent with a possible disease–modifying effect, but early treatment with rasagiline at a dose of 2 mg per day did not. Because the two doses were associated with different outcomes, the study results must be interpreted with caution.
Today in Movement Disorders...keeping you current
Receive free subspecialty "5-minute updates" via email
Paraplegia Following Image-Guided Transforaminal Lumbar Spine Epidural Steroid Injection: Two Case Reports
Pain Medicine, 10/29/09
Progression of Parkinson's disease in the clinical phase: potential markers
The Lancet Neurology, 11/12/09
A comparison of treatment thresholds in two large Parkinsons disease clinical trial cohorts
Movement Disorders, 11/17/09
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
JAMA, 10/29/09
Outcome of intracerebral haemorrhage patients pre-treated with statins
European Journal of Neurology, 11/17/09
Escitalopram and Venlafaxine for the Prophylaxis of Migraine Headache Without Mood Disorders
Clinical Neuropharmacology, 10/02/09
Sponsor
Article Search
Sponsor


See Latest Articles


